Clinical Trial Update: Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis

View source ↗

Summary

Follow-up study of patients previously treated with pimecrolimus tablets for atopic dermatitis; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus tablets (pimecrolimus)

Snippet

Sponsor: Novartis | Conditions: Atopic Dermatitis | Status: COMPLETED